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I. SUPPLEMENTARY NOTE
A. Optical setup
The optical setup of the ISVS system is shown in Supplementary FIG. 2. The beam from the laser (CrystaLaser, CL671-150)
is split into a reference beam and a sample beam by a polarized beam splitter. The reference beam is coupled into a single mode
fiber (FB1, Thorlabs, PM460-HP) for spatial filtering. The filtered beam is collimated by a single lens (L1) and illuminates on
the camera (Phantom S640). The sample beam is coupled into a multimode fiber (FB2, Thorlabs M31L02) and the output beam
is collimated and illuminates on the forehead of the human subject. The diffused light from the human subject is collected by a
large core multimode fiber (Thorlabs M107L02). The output light field of the large core fiber is relayed onto the camera by a 4-f
system (L2 and L3). A beam splitter (BS2) combines the reference beam and sample beam. A custom designed aperture (AP)
is put on the Fourier plane of the 4-f system. A polarizer (P) is put in the sample arm to filter out the cross-polarization portion
of the diffused light. To record the scattered light from the sample using conventional DCS methods, a beam splitter (BS1) is
added in front of BS2 and an SPCM (PerkinElmer, SPCM-AQRH-14) records the scattered light intensity.
B. System implementation on rat experiments
In the dorsal skin flap blood flow monitoring experiments, isoflurane (1-5%) administered in an induction box followed by
maintenance on a nose cone was used to induce anesthesia on a regular laboratory rat. The dorsal skin flap of the rat was shaved
and clipped on a glass slide. The rat was put on a 3-D translational stage and the illumination beam illuminated the dorsal skin
flap. A 4-f system (L2 and L3, Supplementary FIG. 2B) in the optical setup imaged the skin that diffused light.
In the dorsal skin flap blood flow monitoring experiments, ketamine 80-100 mg/kg and xylazine 8-10 mg/kg given via the
intraperitoneal route was used to anesthetize a regular laboratory rat. The skin on the head and the scalp on top of the skull
were surgically removed. The rat was put on a 3-D translational stage and the bregma and lambda areas were identified and
illuminated by a collimated beam. A 4-f system (L2 and L3, Supplementary FIG. 2B) in the optical setup imaged the part of
skull that diffused light. The distance between the illumination spot and the imaging field of view was set about 1 cm.
C. Fourier plane aperture design
To maximize the bandwidth of the signal in the spatial frequency domain, we specifically designed the shape of the aperture
on the Fourier plane of the light collection 4-f system (L2 and L3, Supplementary FIG. 2A). This rectangular shape (shown in
Supplementary FIG. 4A) is different from conventional circular aperture shapes (shown in Supplementary FIG. 4B), since here
we cared primarily about collecting the maximum number of speckles rather than isotropic resolution in conventional imaging.
The lateral size of the aperture was designed to avoid aliasing when performing off-axis holography.
D. The mathematical derivation of equivalent visibility factor
In this section, we derive the second moment of the interference term S(r) in Supplementary Eq. 4 in the main text. Previous
work from1 has shown similar theoretical derivation as shown below, where they analyzed the interferometric detection for
dynamic speckles in ultrasound modulated optical tomography.
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Here g1(t) is the field decorrelation function. Change the integration variable by
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given g1(t) is symmetric. Therefore, Supplementary Eq. 2 can be reduced to
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The equivalent visibility factor is defined as F = 〈|S(r)|
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0 2(1− tT )g1(t) (shown in Eq. 5 in the main text). The definition
of equivalent visibility factor and the conventional SVS visibility factor (Eq. 8 in Ref. 2) have very similar forms, while the only
difference within the integral is that g1(t) in ISVS equivalent visibility factor does not have square. In fact, in Eq. 8 in Ref. 2, the
g1(t)2 comes from the Siegert relation that relates the intensity correlation and field correlation. In our case, the interferometric
detection directly accesses the complex field, and the Siegert relation is not needed. Therefore, when we do correlation operation
on the complex field, we can get the correlation function g1(t) directly, as shown in Supplementary Eq. 1.
If g1(t) has a form of g1(t) = e−t/τ where τ is the speckle decorrelation time, after substituting in Supplementary Eq. 3, we
can get
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As τ  T , τ/T  1 and the equivalent visibility factor F converges to 2τ/T .
In real cases, the equivalent visibility factor calculated from Supplementary Eq. 4 has a non-zero offset. Even when no signal
light photons hit the camera, there is still spatial fluctuations in the cropped side lobes due to camera noise. Taking square and
summing up all the pixels give a non-zero offset that is related to camera noise. Therefore, in the main text FIG. 2B, we use a
camera noise corrected model to describe the equivalent visibility factor.
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In Supplementary Eq. 5, a correction factor β is introduced to compensate the noise associated non-zero offset of F when T/τ
is large. Ideally, β should be 1. The experimental data in the main text FIG. 2B is fitted by the expression of Supplementary Eq.
5 with β equal 0.75.
In Supplementary FIG. 6, we show a figure of equivalent visibility factor F versus T/τ with different β ’s. A small β implies
a relatively large camera noise, therefore the offset of F , which is F = 1−β , is higher.
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II. SUPPLEMENTARY FIGURES
FIG. 1. Flowchart of data processing. (A) The raw frame is Fourier transformed and three lobes contain the information of the reference beam
and sample beam. The yellow enclosed circle and rectangle contain the intensity information of the reference beam and sample beam, and the
red enclosed circle and rectangle contain the information of the equivalent visibility factor and the complex fields. (B) The reference beam
calibration provides the mean value of the reference beam intensity, the red enclosed rectangle in (A) provides the mean value of the energy in
one of the interference lobes, and the yellow enclosed rectangle in (A) provides the mean value of the sample beam intensity after subtracting
the reference beam mean intensity. < ·> denotes the ensemble average over space.
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FIG. 2. Schematic of the optical setup. (A) Optical setup for diffuser experiments. (B) Optical setup for animal experiments. (C) Optical setup
for human experiments. AP, aperture; BS, beam splitter; CAM, camera; FB, fiber; FC, fiber coupler; HWP, half-wave plate; L, lens; M, mirror;
ND, neutral-density filter; P, polarizer; R, rotating diffuser; SPCM, single photon counting module.
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FIG. 3. Results of rat experiments. (A) The results clearly show the breathing signal at 1.5 Hz from both the pulse oximeter and ISVS
equivalent visibility factor signals (four big dips). Pulsatile signals at 3.5 Hz are shown in the pulse oximeter but not clearly shown in ISVS
from the dorsal skin flap. This might be due to less arterial vessels in dorsal skin flap as well as the process of clipping the skin. (B) The
results show the breathing signal at 1.0 Hz from both the pulse oximeter and ISVS equivalent visibility factor signals. Pulsatile blood flow
signals in ISVS couple with the breathing signals in brain signal measurements. (C) The wide field image of the brain bregma area of the rat
using white LED illumination. The pulse oximeter in both measurements samples at 1 kHz. The camera frame rate in the ISVS system in both
measurements is set at 50 Hz and the exposure time is set as 16 ms. The left panel is adapted from Ref. 3.
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FIG. 4. Fourier plane aperture design. (A1) Rectangular aperture. (A2) The Fourier spectrum of an off-axis hologram with a rectangular
aperture. (B1) Circular aperture. (B2) The Fourier spectrum of an off-axis hologram with a circular aperture. Mathematically, it can be shown
that A = 4
√
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B ≈ 1.28B. Therefore, the circular aperture uses 2πA
2/4
(4B)2 ≈ 16% (red circles in (B2) of the Fourier space while the rectangular
aperture uses 50% (red rectangles in (A2)) of the Fourier space. The larger area in Fourier space allows higher light collection efficiency. Scale
bar, 1 cm.
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FIG. 5. Examples of dynamic speckle patterns realized by a single rotating diffuser and two diffusers (one static and one rotating). A series of
translating speckle patterns realized by a single rotating diffuser result in the "smear" effect, while the use of one static and one rotating avoids
such effect.
FIG. 6. Equivalent visibility factor F versus T/τ with different β ’s.
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